Growing community of inventors

San Francisco, CA, United States of America

Matthew J Taylor

Average Co-Inventor Count = 5.39

ph-index = 5

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 166

Matthew J TaylorEldon E Baird (8 patents)Matthew J TaylorJacob A Kaizerman (5 patents)Matthew J TaylorYigong Ge (5 patents)Matthew J TaylorRoland W Burli (3 patents)Matthew J TaylorHeinz Ernst Moser (3 patents)Matthew J TaylorRoland W Bürli (3 patents)Matthew J TaylorRoland W Bürli (2 patents)Matthew J TaylorWenhao Hu (2 patents)Matthew J TaylorAmanda E Martin (2 patents)Matthew J TaylorBrie Cadman (2 patents)Matthew J TaylorDustin L McMinn (1 patent)Matthew J TaylorMatthew J Taylor (8 patents)Eldon E BairdEldon E Baird (9 patents)Jacob A KaizermanJacob A Kaizerman (11 patents)Yigong GeYigong Ge (5 patents)Roland W BurliRoland W Burli (18 patents)Heinz Ernst MoserHeinz Ernst Moser (17 patents)Roland W BürliRoland W Bürli (4 patents)Roland W BürliRoland W Bürli (4 patents)Wenhao HuWenhao Hu (3 patents)Amanda E MartinAmanda E Martin (2 patents)Brie CadmanBrie Cadman (2 patents)Dustin L McMinnDustin L McMinn (31 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Genesoft Pharmaceuticals, Inc. (5 from 9 patents)

2. Genesoft, Inc. (2 from 3 patents)

3. Genesoft Pharmceuticals, Inc. (1 from 1 patent)


8 patents:

1. 7498405 - Halogen-substituted thienyl compounds

2. 7329765 - Benzothiophene compounds having antiinfective activity

3. 7301037 - Charged compounds comprising a nucleic acid binding moiety and uses therefor

4. 7122626 - Halogen-substitued thienyl compounds

5. 7078536 - Charged compounds comprising a nucleic acid binding moiety and uses therefor

6. 6825228 - Benzothiophene compounds having antiinfective activity

7. 6716866 - Aryl-benzimidazole compounds having antiinfective activity

8. 6555693 - Charged compounds comprising a nucleic acid binding moiety and uses therefor

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…